Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Pkd1l3 (polycystin 1 like 3, transient receptor potential channel interacting) Rattus norvegicus
Symbol: Pkd1l3
Name: polycystin 1 like 3, transient receptor potential channel interacting
Description: Predicted to contribute to cation channel activity and sour taste receptor activity. Predicted to be involved in several processes, including cellular response to acidic pH; detection of chemical stimulus involved in sensory perception of sour taste; and detection of mechanical stimulus. Predicted to colocalize with the cell surface. Orthologous to human PKD1L3 (polycystin 1 like 3, transient receptor potential channel interacting); INTERACTS WITH aflatoxin B1 (ortholog); butanal (ortholog); lead diacetate (ortholog).
Type: protein-coding
RefSeq Status: MODEL
Also known as: LOC100362565; polycystic kidney disease 1 like 3-like; polycystic kidney disease 1-like 3; polycystic kidney disease protein 1-like 3
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Rat AssemblyChrPosition (strand)SourceGenome Browsers
Rnor_6.01941,990,249 - 42,054,390 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01952,814,619 - 52,879,420 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41939,489,363 - 39,555,398 (+)NCBIRGSC3.4rn4RGSC3.4
Celera1936,990,385 - 37,053,340 (+)NCBICelera
Cytogenetic Map19q12NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated
RGD Disease Portals


Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status


Nucleotide Sequences
Protein Sequences

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
More on Pkd1l3
Alliance Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 2324490
Created: 2010-05-06
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.